Trials / Completed
CompletedNCT05577806
DYG Versus Cetrorelix in Oocyte Donation
Comparison of Reproductive Outcomes After Progestin-primed Ovarian Stimulation With Dydrogesterone Versus Cetrorelix to Inhibit Spontaneous Ovulation in Oocyte Donation
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 202 (estimated)
- Sponsor
- Clinica de la Mujer Medicina Reproductiva, Chile · Academic / Other
- Sex
- Female
- Age
- 21 Years – 30 Years
- Healthy volunteers
- —
Summary
Prospective controlled study to assess the reproductive outcomes of OD recipients in which the donors were subjected to the DYG protocol (20mg/day) compared with those subjected to the short protocol with cetrorelix (0.25 mg/day) from Day 7 or since a leading follicle reached 14 mm. The OD cycles were triggered with triptoreline acetate and the trigger criterion was ≥3 follicles of diameter \>18mm.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dydrogesterone | progestin primed ovarian stimulation |
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2021-12-31
- Completion
- 2021-12-31
- First posted
- 2022-10-13
- Last updated
- 2022-10-13
Source: ClinicalTrials.gov record NCT05577806. Inclusion in this directory is not an endorsement.